Source: Annual Congress 2006 - Recent advances in the treatment of COPD and acute lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Bathoorn, D. J. Slebos, D. S. Postma, A. J. M. van Oosterhout, H. A. M. Kerstjens (Groningen, Netherlands). Effects of low dose inhaled carbon monoxide in patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 3840

Member's Comments

No comment yet.

Related content which might interest you: Comparison of exhaled carbon monoxide between patients with high dose and lowdose exposure to mustard gas Source: Annual Congress 2008 - The biology of smoking and COPD Year: 2008 Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study Source: Eur Respir J 2007; 30: 1131-1137 Year: 2007 The importance of measuriing exhaled carbon monoxide in asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003 Exhaled carbon monoxide levels during treatment of acute asthma Source: Eur Respir J 2001; 17: 1336 Year: 2001 Increased ventilatory response to carbon dioxide in COPD patients following vitamin C administration Source: ERJ Open Res 2015 Year: 2015 Influence of ventilation inhomogeneity on diffusing capacity of carbon monoxide in smokers without COPD Source: ERJ Open Res, 7 (1) 00706-2020; 10.1183/23120541.00706-2020 Year: 2021 Exhaled nitric oxide and carbon monoxide are not markers of disease activity in asthma patients on reducing doses of inhaled steroids: a longitudinal study Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001 Increase of exhaled carbon monoxide in subjects with non-controlled asthma Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Exhaled carbon monoxide as a marker of tobacco exposure: is it possible to use the same parameters in COPD patients? Source: Eur Respir J 2006; 28: Suppl. 50, 389s Year: 2006 Alcohol effects on diffusing capacity of the lung for carbon monoxide (DLCO) in healthy subjects and in COPD patients Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010 Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002 Effect of inhaled carbon monoxide on lipopolysaccharide-induced acute lung injury in mice Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004 Exhaled carbon monoxide level is higher in steroid naïve asthmatic children comparing to healthy individuals Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Assessment of low dose effects of acute sulfur dioxide exposure on the airways using non-invasive methods Source: Annual Congress 2008 - Air pollution effects on lung and heart Year: 2008 Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 Effects of supplemental oxygen and high-dose inhaled bronchodilator therapy in exercise performance and dyspnoea in patients with stable COPD Source: Annual Congress 2004 - Exercise and systemic effects in COPD Year: 2004 Carbon monoxide pollution is associated with decreased lung function in asthmatic adults Source: Eur Respir J 2010; 35: 266-272 Year: 2010 Preliminary results of the evaluation of exhaled carbon monoxide levels in patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 217s Year: 2001 The acute impact of exercise test on exhaled carbon monoxide rate Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy Year: 2017 Methacholine-induced bronchoconstriction does not modify exhaled carbon monoxide level in asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 165s Year: 2001